Professor Nathaniel (Ned) R. Landau

Dr. Landau is a tenured Professor in the Department of Microbiology at the NYU School of Medicine.  He did his doctoral thesis under the supervision of Dr. David Baltimore at MIT where he cloned the gene for the enzyme terminal deoxynucleotidyl transferasem, the first mamallian gene cloned by antibody screening, and then identified its role in the diversification of immunoglobulin genes.  Upon completing his doctoral studies in 1987, he joined Dan Littman’s lab at UCSF to do post-doctoral studies on HIV entry.  He then became a staff scientist at the Aaron Diamond AIDS Research Center where his studies centered on HIV accessory gene and host cofactors for HIV replication.  His laboratory identified CCR5 as a coreceptor for HIV primary and in collaboration with the laboratory of Dr. Richard Koup, identified delta32-ccr5, the deleted ccr5 allele that leads to resistance to HIV infection. 


He later moved to the Salk Institute where he continued to work on host restriction factors, focusing on Vif/APOBEC3, Vpr and Vpx.  Dr. Landau’s current focus is on HIV restriction factors and dendritic cell vaccines. Dr. Landau was the recipient of an Elizabeth Glaser Pediatric AIDS Scientist award,  and an Avant Garde award from the NIH National Institutes of Health.  His works was featured in the American Foundation for AIDS Research Documentary “The Battle of AmfAR".  Dr. Landau was a permanent member of the NIH AIDS Molecular and Cell Biology grant review panel and continues to serve as an ad hoc reviewer on NIH grant review panels.  He was a long time member of the Conference on Retroviruses and Opportunistic Infection program committee and a co-organizer of the Cold Spring Harbor Retrovirus meeting and West Coast Retrovirus meeting.  He is the holder of patents related to HIV reporter viruses, lentiviral vectors and the delta32-ccr5 allele.


Department of Microbiology

Alexandria Center for Life Science - West Tower

430 East 29th Street
Office Rm. 509, Lab Rm. 524
New York, NY 10016
Direct Line: (212) 263-9197
Fax: (646) 501-4645